EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

More T cell receptors to the RAScue in cancer?

Eric Tran

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci184782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Eric Tran. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment with T cells genetically engineered to express tumor-reactive T cell receptors (TCRs), known as TCR-gene therapy (TCR-T), is a promising immunotherapeutic approach for patients with cancer. The identification of optimal TCRs to use and tumor antigens to target are key considerations for TCR-T. In this issue of the JCI, Bear and colleagues report on their use of in vitro assays to characterize four HLA-A*03:01- or HLA-A*11:01-restricted TCRs targeting the oncogenic KRAS G12V mutation. The TCRs were derived from healthy donors or patients with pancreatic cancer who had received a vaccine against mutant KRAS. The most promising TCRs warrant testing in patients with KRAS G12V-positive cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-CellProto-Oncogene Proteins p21(ras)HumansPancreatic NeoplasmsT-LymphocytesAntigens, NeoplasmNeoplasmsMutation, MissenseMutationHLA-A AntigensCancer Vaccines

Substanzen

Receptors, Antigen, T-CellProto-Oncogene Proteins p21(ras)KRAS protein, humanAntigens, NeoplasmHLA-A AntigensCancer Vaccines

Zitieren

APA

Tran, E. (2024). More T cell receptors to the RAScue in cancer?. Journal of Clinical Investigation. https://doi.org/10.1172/jci184782

Vancouver

Tran E. More T cell receptors to the RAScue in cancer?. Journal of Clinical Investigation. 2024. doi:10.1172/jci184782

BibTeX
@article{Tran2024,
  author = {Tran, Eric},
  title = {More T cell receptors to the RAScue in cancer?},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci184782}
}
Kostenlos starten →